123 related articles for article (PubMed ID: 24322883)
1. Steroid-resistant relapsing IgG4-related pachymeningitis treated with methotrexate.
Hyun JW; Kim SH; Yoo H; Hong EK; Huh SY; Kim HJ
JAMA Neurol; 2014 Feb; 71(2):222-5. PubMed ID: 24322883
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment.
Lu LX; Della-Torre E; Stone JH; Clark SW
JAMA Neurol; 2014 Jun; 71(6):785-93. PubMed ID: 24733677
[TBL] [Abstract][Full Text] [Related]
3. Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab.
Gospodarev V; Câmara J; Chakravarthy V; Perry A; Wood M; Dietz R; Wang J; De Los Reyes K; Raghavan R
J Neuroimmunol; 2016 Oct; 299():62-65. PubMed ID: 27725123
[TBL] [Abstract][Full Text] [Related]
4. Probable IgG4-related pachymeningitis: a case with transverse sinus obliteration.
Tanboon J; Felicella MM; Bilbao J; Mainprize T; Perry A
Clin Neuropathol; 2013; 32(4):291-7. PubMed ID: 23320997
[TBL] [Abstract][Full Text] [Related]
5. Investigation of IgG4-positive cell infiltration in biopsy specimens from cases of hypertrophic pachymeningitis.
Utsuki S; Kijima C; Fujii K; Miyakawa S; Iizuka T; Hara A
Clin Neuropathol; 2013; 32(2):84-90. PubMed ID: 23211431
[TBL] [Abstract][Full Text] [Related]
6. Marked effectiveness of low-dose oral methotrexate for steroid-resistant idiopathic hypertrophic pachymeningitis: Case report.
Uchida H; Ogawa Y; Tominaga T
Clin Neurol Neurosurg; 2018 May; 168():30-33. PubMed ID: 29510265
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic hypertrophic cranial pachymeningitis successfully treated with weekly subcutaneous methotrexate.
Ruiz-Sandoval JL; Bernard-Medina G; Ramos-Gómez EJ; Romero-Vargas S; Gutiérrez-Ureña S; González-Cornejo S; Chiquete E
Acta Neurochir (Wien); 2006 Sep; 148(9):1011-4. PubMed ID: 16614804
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis.
Della-Torre E; Galli L; Franciotta D; Bozzolo EP; Briani C; Furlan R; Roveri L; Sessa M; Passerini G; Sabbadini MG
J Neuroimmunol; 2014 Jan; 266(1-2):82-6. PubMed ID: 24289956
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for corticosteroid-resistant relapsing IgG4-related intracranial pachymeningitis: report of two cases.
Mageau A; Shor N; Fisselier M; Aboab J; Lecler A; Rebours C; Adle-Biassette H; Gout O; Deschamps R
Pract Neurol; 2018 Apr; 18(2):159-161. PubMed ID: 29208730
[TBL] [Abstract][Full Text] [Related]
11. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease.
Chan SK; Cheuk W; Chan KT; Chan JK
Am J Surg Pathol; 2009 Aug; 33(8):1249-52. PubMed ID: 19561447
[TBL] [Abstract][Full Text] [Related]
12. Refractory IgG4-related disease complicated with organising pneumonia and hypertrophic pachymeningitis.
Abe F; Michishita Y; Saito M; Nara M; Wakui H; Takahashi N
Mod Rheumatol Case Rep; 2022 Jun; 6(2):278-281. PubMed ID: 35355069
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
Popkirov S; Kowalski T; Schlegel U; Skodda S
J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G4-related hypertrophic pachymeningitis involving cerebral parenchyma.
Kim EH; Kim SH; Cho JM; Ahn JY; Chang JH
J Neurosurg; 2011 Dec; 115(6):1242-7. PubMed ID: 21854114
[TBL] [Abstract][Full Text] [Related]
16. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis].
Iwanami M; Ogawa T; Tanaka Y; Hyoudo A; Ueda Y; Miyamoto T
Rinsho Shinkeigaku; 2014; 54(1):52-5. PubMed ID: 24429649
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review.
Melenotte C; Seguier J; Ebbo M; Kaphan E; Bernit E; Saillier L; Audoin B; Feyeux D; Daniel L; Roche PH; Graillon T; Dufour H; Boutière C; Girard N; Closs-Prophette F; Guillaud C; Tieulié N; Regent A; Harlé JR; Hamidou M; Mekinian A; Grados A; Schleinitz N
Semin Arthritis Rheum; 2019 Dec; 49(3):430-437. PubMed ID: 31155444
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate for lung transplant recipients with steroid-resistant acute rejection.
Cahill BC; O'Rourke MK; Strasburg KA; Savik K; Jessurun J; Bolman RM; Hertz MI
J Heart Lung Transplant; 1996 Nov; 15(11):1130-7. PubMed ID: 8956122
[TBL] [Abstract][Full Text] [Related]
19. [Central and peripheral nervous system involvement in immunoglobulin G4-related disease].
Kosakai A
Brain Nerve; 2013 Nov; 65(11):1343-52. PubMed ID: 24200612
[TBL] [Abstract][Full Text] [Related]
20. Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case.
Elmaci I; Altinoz MA; Akdemir G; Sari R; Baskan O; Ozpinar A; Hacker E; Sav A
Clin Neurol Neurosurg; 2021 Jan; 200():106342. PubMed ID: 33158629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
